Compare Procter & Gamble Health with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DR. REDDYS LAB - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DR. REDDYS LAB PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
 
P/E (TTM) x 41.0 33.0 124.1% View Chart
P/BV x 4.4 4.6 94.4% View Chart
Dividend Yield % 10.8 0.5 2,126.7%  

Financials

 PROCTER & GAMBLE HEALTH   DR. REDDYS LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
DR. REDDYS LAB
Mar-19
PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,5492,875 123.4%   
Low Rs1,3011,888 68.9%   
Sales per share (Unadj.) Rs511.4930.2 55.0%  
Earnings per share (Unadj.) Rs61.3117.4 52.2%  
Cash flow per share (Unadj.) Rs74.0185.8 39.8%  
Dividends per share (Unadj.) Rs440.0020.00 2,200.0%  
Dividend yield (eoy) %18.10.8 2,160.4%  
Book value per share (Unadj.) Rs927.8844.4 109.9%  
Shares outstanding (eoy) m16.60166.07 10.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.72.6 185.2%   
Avg P/E ratio x39.620.3 195.1%  
P/CF ratio (eoy) x32.812.8 255.6%  
Price / Book Value ratio x2.62.8 92.7%  
Dividend payout %717.917.0 4,214.9%   
Avg Mkt Cap Rs m40,257395,496 10.2%   
No. of employees `0001.122.0 5.2%   
Total wages/salary Rs m1,31333,562 3.9%   
Avg. sales/employee Rs Th7,486.77,032.8 106.5%   
Avg. wages/employee Rs Th1,157.61,527.9 75.8%   
Avg. net profit/employee Rs Th897.2887.7 101.1%   
INCOME DATA
Net Sales Rs m8,490154,482 5.5%  
Other income Rs m2443,375 7.2%   
Total revenues Rs m8,734157,857 5.5%   
Gross profit Rs m1,48231,782 4.7%  
Depreciation Rs m21111,348 1.9%   
Interest Rs m0889 0.0%   
Profit before tax Rs m1,51422,920 6.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5633,858 14.6%   
Profit after tax Rs m1,01719,500 5.2%  
Gross profit margin %17.520.6 84.8%  
Effective tax rate %37.116.8 220.7%   
Net profit margin %12.012.6 94.9%  
BALANCE SHEET DATA
Current assets Rs m15,343111,101 13.8%   
Current liabilities Rs m1,96058,973 3.3%   
Net working cap to sales %157.633.7 467.1%  
Current ratio x7.81.9 415.5%  
Inventory Days Days4979 61.4%  
Debtors Days Days2894 30.2%  
Net fixed assets Rs m1,209101,245 1.2%   
Share capital Rs m166830 20.0%   
"Free" reserves Rs m15,235139,406 10.9%   
Net worth Rs m15,401140,236 11.0%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m17,595224,656 7.8%  
Interest coverage xNM26.8-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.50.7 70.2%   
Return on assets %5.89.1 63.7%  
Return on equity %6.613.9 47.5%  
Return on capital %10.314.9 68.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,63688,673 1.8%   
Fx outflow Rs m4,36819,104 22.9%   
Net fx Rs m-2,73269,569 -3.9%   
CASH FLOW
From Operations Rs m-1,30428,704 -4.5%  
From Investments Rs m12,697-7,727 -164.3%  
From Financial Activity Rs m-301-21,326 1.4%  
Net Cashflow Rs m11,093-314 -3,532.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.4 337.0%  
FIIs % 1.0 35.3 2.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 29.1 15.3 190.2%  
Shareholders   28,591 75,885 37.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUVEN LIFESCIENCES  SHASUN PHARMA  SANOFI INDIA  TTK HEALTHCARE  SUN PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down 513 Points; Banking and Auto Stocks Witness Huge Selling(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 14, 2020 01:03 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS